Remove Finance Remove Human Resources Remove Pharmaceuticals Remove Process
article thumbnail

6 Proven Tactics to Design an Effective Executive Healthcare Resume

Strategy Driven

Crafting and writing a branded healthcare executive resume, that differs from the traditional medical resume, can make a significant difference in your executive job search results and improve the opportunities to land that next-level position in pharmaceutical, biotech and medical device industries. You must appeal to all of these audiences.

Tactics 53
article thumbnail

The Questions Executives Should Ask About 3D Printing

Harvard Business Review

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Carmakers have started using 3D technology to produce parts. And last year saw the first demonstration of a digital printer producing multilayer, standards-based circuit boards.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

This Pharma Company Stays Innovative by Doing Two Things

Harvard Business Review

In a recent Gallup poll , the pharmaceutical industry was the most widely disliked private industry, ranking even lower than lawyers. ” Meanwhile, the company recruited non-scientist talent from finance, consulting, tech, academia, and political campaigns and inserted them into drug-development roles.

article thumbnail

Using Supply Chains to Grow Your Business

Harvard Business Review

Corporate procurement processes are opaque, secretive, and can be influenced by political pull as well as pure performance. In the clubby world of pharmaceutical purchasing executives, PACIV’s reputation for transparency spread, setting a higher bar that his competitors begrudgingly were now asked to jump over.

article thumbnail

The Internet of Things Will Change Your Company, Not Just Your Products

Harvard Business Review

In addressing the billion-dollar adherence problem, Vitality (since acquired by NANTHEALTH ) considered the interests of the players in the diverse ecosystem, including pharmaceutical companies, retail pharmacies, and health care providers. Human resources. It also took into account their roles in changing patient behavior.